Adult-to-adult living donor liver transplantation for acute liver failure in China

Table 5 Adult-to-adult living donor liver transplantation for acute liver failure between 2000 and 2010

Study	Recipient									Donor complications
	Cases	MELD	Waiting time (d)	Graft type			GV/SLV (%)	Mortality	Survival rate, n (%)	Cases	Minor	Major	Morbidity
				Right	Left	Dual
Park et al[2]	40	36	2.5	35	0	6	ND	6	1 (85)	45	11	0	24.40%
Shi-Chun et al[3]	10	34.5 ± 2.1	3	10	0	0	56.7 (47.7-66.9)	2	2 (80)	10	4	0	40%
Ikegami et al[4,12]	44	24 ± 6	8 ± 6	12	32	10	22.8-56.8	10	1 (78.3); 3 (71.6)	44	15	0	34%
Campsen et al[5]	10	> 21	2.7	10	0	0	ND	3	1-5 (70)	10	5	0	50%
Matsui et al[13]	36 (4)1	22 ± 6	ND	18	16	0	46 (22-75)	4	1 (94); 5 (87)	36	1	1	5.60%
Rajekar et al[14]	15	32	ND	ND			ND	3	4 (80)	ND	ND	ND	ND
Lee et al[15]	57	32	2.4	33	9	15	27-81	10	1-5 (82)	72	ND	ND	ND
Liu et al[16]	32	36 ± 1.8	2.5	32	0	0	52 (33-87)	4	2 (88)	32	8	2	31.30%
Nishizaki et al[17]	15	ND	5	0	15	0	36.7 (23-54)	3	1 (80)	15	ND	ND	ND

¹Four pediatric recipients were not clarified from 36 cases in this report. Major complications of donors were defined as the Clavine grade III-IV. MELD: Model for end-stage liver disease; GV/SLV: Graft volume to recipient standard liver volume; ND: Not described. The latest report was as the summarized standard if multiple reports were from the same center and author.